Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uveal Melanoma × Sorafenib × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 42 Liver Neoplasms 7 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Pancreatic Neoplasms 3 Melanoma 3 Carcinoma, Renal Cell 3 Sarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Breast Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Relapsed Pediatric Solid Tumor 1 Portal Vein Tumor Thrombus 1 Neoplasms, Glandular and Epithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Hemangiosarcoma 1 HCC 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Digestive System Neoplasms 1

Interventions

Ipilimumab 3 Triamcinolone Acetonide 2 Ranibizumab 2 Nivolumab 2 Amplified Fragment Length Polymorphism Analysis 2 salicylhydroxamic acid 1 aldesleukin 1 Ultrasonography 1 Tramadol 1 Temozolomide 1 Tamoxifen 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Rose Bengal 1 Pharmacogenomic Testing 1 Melphalan 1 Ibuprofen 1 Eye Enucleation 1 Cyclophosphamide 1 Cisplatin 1 Chemotherapy, Adjuvant 1 CTLA-4 Antigen 1 Brachytherapy 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01377025 2014-12-03

STREAM

University Hospital, Essen

Phase 2 Unknown

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡